Ä¢¹½ÊÓƵAPP

Skip to content

Paul Parker

Managing Partner, Capital Solutions and Value Realization

Paul Parker joined Flagship in 2024 as Managing Partner, Capital Solutions and Value Realization. In this role, Paul leads all capital solutions efforts at Flagship, driving portfolio value realization, fundraising activities, and building and managing Flagship’s relationships with Limited Partners as well as strategic and financial investors. He also plays a key role on Flagship’s senior leadership team, helping drive value, impact, and effectiveness across the organization.

Paul brings over 35 years of experience in banking, pharma and biotech, as well as in mergers and acquisitions (M&A), corporate strategy and organizational leadership. He has worked across multiple sectors and geographies, built and managed several multi-billion-dollar businesses, and led teams of several thousand employees.

Prior to joining Flagship, Paul was a Corporate Officer, member of the Company Leadership Team, and served as Senior Vice President, Strategy and Corporate Development for Thermo Fisher Scientific. In this capacity he held a number of enterprise-level operating roles, including having responsibility for Corporate Strategy, Corporate Development, Strategic Capital, Integration Management, Corporate Social Responsibility, and Government Relations. He previously served as Co-Chairman of the Global Mergers and Acquisitions Group for Goldman Sachs & Co. and served on the firm's Partnership Committee and the Investment Banking Senior Leadership Council. Prior to Goldman Sachs, Paul held senior positions at Barclays Group Plc where he served as Chairman and Head of Global M&A, subsequently adding responsibilities as Co-Head of Corporate Finance. He was previously an investment banker at Lehman Brothers in several senior leadership positions, ultimately serving as Chairman and Head of Global M&A. Earlier in his career, Parker held positions at other financial institutions, including J.P. Morgan & Co.

Paul previously served as a Board member of The Clorox Company from 2020-2024.

He earned an MBA with distinction from Harvard Business School and a bachelor's degree in international studies from the University of North Carolina at Chapel Hill.